MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,201,987 | -74.0% | 124,637 | -58.9% | 0.61% | -70.0% |
| Q2 2023 | $69,989,997 | -55.6% | 302,987 | -53.4% | 2.03% | -56.5% |
| Q1 2023 | $157,605,150 | -47.4% | 650,562 | -37.0% | 4.65% | -44.7% |
| Q4 2022 | $299,518,263 | +1292.3% | 1,031,932 | +211.7% | 8.41% | +1247.9% |
| Q3 2022 | $21,513,000 | -18.2% | 331,023 | -9.9% | 0.62% | -24.3% |
| Q2 2022 | $26,306,000 | -3.7% | 367,501 | +32.1% | 0.82% | +50.6% |
| Q1 2022 | $27,305,000 | +86.5% | 278,286 | +61.0% | 0.55% | +384.1% |
| Q4 2021 | $14,644,000 | +2989.5% | 172,800 | +7708.4% | 0.11% | +769.2% |
| Q3 2018 | $474,000 | -94.7% | 2,213 | -93.1% | 0.01% | -94.5% |
| Q2 2018 | $9,010,000 | -45.9% | 32,213 | -77.4% | 0.24% | -49.4% |
| Q1 2018 | $16,645,000 | -4.0% | 142,522 | -24.5% | 0.47% | -19.0% |
| Q4 2017 | $17,338,000 | – | 188,893 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |